Related Experiment Video

Updated: Apr 23, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Molecular insights into the development of T cell-based immunotherapy for prostate cancer

Baijun Dong1, Laurie J Minze, Wei Xue

  • 1Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, P.R., China.

Expert Review of Clinical Immunology
|September 27, 2014
PubMed

Insights

Cancer immunotherapy harnesses the patient's immune system to combat cancer. Research focuses on prostate cancer vaccines like sipuleucel-T and immune checkpoint inhibitors, such as ipilimumab and nivolumab, to enhance T-cell responses.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Cancer immunotherapy aims to leverage the patient's immune system for tumor treatment.
  • Sipuleucel-T, the first approved prostate cancer vaccine, enhances T-cell immunity against metastatic castration-resistant prostate cancer.
  • Other prostate cancer immunotherapies, including PROSTVAC-VF, GVAX, and immune checkpoint inhibitors (ipilimumab, nivolumab), are under investigation.

Purpose of the Study:

  • To review the mechanisms of anti-tumor T-cell responses.
  • To discuss the development of immunotherapies for prostate cancer.

Main Methods:

  • Review of existing research on cancer vaccines and immune checkpoint inhibitors.
  • Discussion of T-cell mediated anti-tumor immune responses.

Main Results:

  • Sipuleucel-T is an established immunotherapy for prostate cancer.
  • PROSTVAC-VF and GVAX are investigational prostate cancer vaccines.
  • Immune checkpoint inhibitors ipilimumab and nivolumab show potential in reversing immunologic tolerance in various cancers, including prostate cancer.

Conclusions:

  • Immunotherapy represents a significant advancement in cancer treatment.
  • Ongoing research continues to explore novel strategies for enhancing anti-tumor immunity in prostate cancer.
Keywords:
T cellscancer vaccineimmune checkpointimmunotherapyprostate cancersipuleucel-T

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K